No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Monthly Information on Share Capital and Company Voting Rights
Cellectis S.A. Updates UCART Pipeline With Phase 2 Trial Details
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
JMP Securities Maintains Cellectis(CLLS.US) With Buy Rating, Maintains Target Price $6
Cellectis Reports 2024 Financial Results and Strategic Progress
Cellectis Reports 2024 Financial Results and Strategic Advances